Prostate cancer statistics

Cases

New cases of prostate cancer, 2011, UK

Deaths

Deaths from prostate cancer, 2012, UK

Survival

Survive prostate cancer for 10 or more years, 2010-11, England and Wales

Prevention

Preventable cases of prostate cancer are not known as it is not clearly linked to any preventable risk factors

  • Prostate cancer is the most common cancer in men in the UK. 
  • Prostate cancer accounts for a quarter of all new cancer cases in men in the UK.
  • In 2011 in the UK around 41,700 men were diagnosed with prostate cancer, that's more than 110 every day. 
  • Over the last 35 years prostate cancer rates in Great Britain have more than tripled, although much of the increase is due to increased detection through widespread use of the PSA test.
  • More than a third of prostate cancer cases are diagnosed in men aged over 75 years.
  • In Europe, around 417,000 new cases of prostate cancer were estimated to have been diagnosed in 2012. The UK incidence rate is 17th highest in Europe.
  • Worldwide, more than 1.11 million men were estimated to have been diagnosed with prostate cancer in 2012, with incidence rates varying across the world.

Read more in-depth prostate cancer incidence statistics

  • Prostate cancer is the second most common cause of cancer death in UK men, after lung cancer.
  • In 2012 in the UK around 10,800 men died from prostate cancer, that's 30 every day.
  • Almost three quarters of prostate cancer deaths occur in men aged 75 and over.
  • Prostate cancer death rates peaked in the early 1990s and have since fallen by around a fifth.
  • In Europe, around 92,300 men were estimated to have died from prostate cancer in 2012. The UK mortality rate is 15th highest in Europe.
  • Worldwide, more than 307,000 men were estimated to have died from prostate cancer in 2012, with mortality rates varying across the world.

Read more in-depth prostate cancer mortality statistics

  • In the 1970s, almost 4 in 10 men diagnosed with prostate cancer survived their disease beyond five years, now it’s more than 8 in 10; however, much of this increase can be attributed to the increased use of PSA testing in the UK, which has led to the diagnosis of many prostate cancers which would have gone undetected.
  • Forty years ago, more than 2 in 10 men diagnosed with prostate cancer survived their disease for at least ten years, now it is more than 8 in 10; however, much of this increase can be attributed to the increased use of PSA testing in the UK which has led to the diagnosis of many prostate cancers which would have gone undetected.
  • Out of 20 common cancers in England and Wales, ten-year survival for prostate cancer ranks 3rd highest.

Read more in-depth prostate cancer survival statistics

  • Prostate cancer is not clearly linked to any preventable risk factors.
  • A man’s risk of developing prostate cancer depends on many factors, including age,genetics, and possibly exposure to risk factors.
  • No modifiable factors have been conclusively linked with prostate cancer risk, though many factors have been studied. Use of PSA testing often makes interpretation of evidence difficult.
  • Some factors may relate to higher prostate cancer risk, including certain occupational exposures, ionising radiation, and certain medical conditions, but evidence is unclear.
  • Some foods and supplements may relate to lower prostate cancer risk, but evidence is unclear.

Read more in-depth prostate cancer risk factors

The latest statistics available for prostate cancer in the UK are; incidence 2011, mortality 2012 and survival 2010-2011.

The ICD code Open a glossary item for prostate cancer is ICD-10 C61.

Survival statistics give an overall picture of survival and (unless otherwise stated) include all adults (15-99) diagnosed, at all ages, stages Open a glossary item and co-morbidities Open a glossary item. The survival time experienced by an individual patient may be much higher or lower, depending on specific patient and tumour characteristics.

Survival by stage is not yet routinely available for the UK due to inconsistencies in the collecting and recording of staging data in the past. Survival by stage is available for the former Anglia Cancer Network in the east of England, however. The former Anglia Cancer Network covers around 5% of the population of England and may not be representative of the country as a whole due to differences in underlying demographic factors (such as age, deprivation or ethnicity), as well as variation in local healthcare provision standards and policies.

Meta-analyses Open a glossary item and systematic reviews Open a glossary item are cited on this page where available, as they provide the best overview of all available research and most take study quality into account. Individual case-control and cohort studies Open a glossary item are reported where such aggregated data are lacking.

Citation

You are welcome to reuse this Cancer Research UK statistics content for your own work.

Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year]. 

Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK. 

Acknowledgements

We would like to acknowledge the essential work of the cancer registries in the United Kingdom and Ireland Association of Cancer Registries, without which there would be no data.

Rate this page:

Currently rated: 5 out of 5 based on 2 votes
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page